Menopause-related DNA damage and gene-activity changes in Alzheimer's

The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease

['FUNDING_R01'] · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · NIH-11118919

This project explores whether DNA damage and shifts in gene activity during menopause help explain why more women develop Alzheimer's disease.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MIAMI SCHOOL OF MEDICINE (nih funded)
Locations1 site (CORAL GABLES, UNITED STATES)
Trial IDNIH-11118919 on ClinicalTrials.gov

What this research studies

From a patient's view, this work looks at how the hormonal changes of menopause might cause DNA damage and change gene 'switches' in the brain that could speed Alzheimer's in women. The team will use mouse models that mimic a gradual menopause transition and will analyze brain tissue from about 300 people to track DNA repair enzymes and epigenetic marks. They will compare patterns between females and males and test how menopause-like conditions alter memory-related molecular pathways. The aim is to connect menopause-linked molecular changes to the higher Alzheimer’s risk observed in women.

Who could benefit from this research

Good fit: Women in perimenopause or postmenopause and people interested in how hormonal changes affect Alzheimer's risk would be most relevant to this work.

Not a fit: People whose Alzheimer's is unrelated to sex-hormone changes, including many men, may not receive direct benefit from menopause-focused findings.

Why it matters

Potential benefit: If successful, the research could identify targets to prevent or treat Alzheimer's in women by correcting DNA repair or epigenetic changes tied to menopause.

How similar studies have performed: Previous animal and molecular studies suggest hormones affect brain epigenetics and memory, but applying gradual menopause models alongside large-scale human brain analyses is relatively novel.

Where this research is happening

CORAL GABLES, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.